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Difﬁcult endoscopic retrograde cholangiopancreatography in cancer patients
Jeffrey H. Lee*, Amanpal Singh
a b s t r a c t
Endoscopic drainage of malignant biliary obstruction can be challenging. For patients in whom conventional wire-guided cannulation or precut attempts
are unsuccessful, an endoscopic ultrasound-guided approach may be helpful. Concomitant duodenal strictures occur in 10–20% of patients with
malignant biliary obstruction from pancreatic cancer. Gastric outlet obstruction due to a duodenal stricture can be relieved either by endoscopic
gastroduodenal stent placement or gastrojejunostomy. In this setting, simultaneous stenting of the bile duct and duodenal strictures should be
considered. In this review article, we highlight the issues involved in performing endoscopic retrograde cholangiopancreatography in patients with
malignancy and present a review of literature describing techniques to overcome the challenges.
Copyright  2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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In 1980, Laurence and Cotton1 described two cases where
duodenoscopewas used for drainage of malignant biliary strictures.
Since then this procedure has gained wider acceptance than
surgical or percutaneous methods. Today, endoscopic retrograde
cholangiopancreatography (ERCP) is a widely used endoscopic
procedure to relieve biliary obstruction caused by benign as well as
malignant causes. Technical success of this procedure depends on
the ability to reach and cannulate the papilla. This can be chal-
lenging in patients with underlying malignancy. In this review, we
would like to highlight the various issues that relate to difﬁcult
ERCP in patients with malignancy.
Preparation for ERCP
Prior to starting a difﬁcult ERCP, an endoscopist ought to study the
patient’s clinical history, indications for the procedure, and available
imaging studies [computed tomography or magnetic resonance
imaging (magnetic resonance cholangiopancreatography)]. Key
information that can be extracted from the imaging studies includes
the following:
 Patient’s anatomy: Imaging studies show whether a patient has
altered anatomy, such as gastric bypass, gastrojejunostomy,
Billroth I or II, esophagectomy, pancreaticoduodenectomy, orDepartment of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderso
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(gastric, duodenal) strictures that may prevent passage of the
endoscope. If the patient has gastric outlet obstruction from
pancreatic or duodenal cancer, airway protection via intubation
should be considered to prevent aspiration pneumonia.
 Location of the biliary stricture: If the obstruction or stricture of
the bile duct is in the extrahepatic segment of the biliary tree,
endotherapy to remove the cause of biliary obstruction or
stenting the extrahepatic bile duct would be sufﬁcient to re-
establish bile drainage. For hilar obstruction and/or intra-
hepatic ductal strictures, studies comparing unilateral and
bilateral stenting have yielded conﬂicting results. Cumulative
patency durations appear to be better with bilateral stenting
than with unilateral stenting, especially for patients with chol-
angiocarcinoma.2 Occurrence of cholangitis as a procedural
complication appears to be related to the injection of contrast
material into a system without subsequent drainage.3,4 Hence,
a thorough assessment of imaging studies is a requisite to plan
appropriate segmental drainage of the liver for effective biliary
decompression. Cannulation and contrast injection of non-
drainable segments should be avoided to minimize the risk of
cholangitis.
In a retrospective, two-center study, 107 patients with hilar
strictures were endoscopically managed. The authors found that
draining more than 50% of the liver volume was associated withn Cancer Center, Houston, TX, USA
University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit
on. Published by Elsevier. All rights reserved.
Fig. 1. Patient with pancreatic cancer presented with a duodenal stricture and
obstructive jaundice. Conventional ERCP was not possible. The bile duct was accessed
via EUS guidance (rendezvous). ERCP, endoscopic retrograde cholangiopancreatog-
raphy; EUS, endoscopic ultrasound.
Gastrointestinal Intervention 2012 1(1), 19–2420effective drainage [odds ratio (OR) 4.5; P ¼ 0.001] and a longer
median survival (119 vs. 59 days; P ¼ 0.005). Injection into an
atrophic sector increased the risk of cholangitis (OR 3.04;
P ¼ 0.01).5 No signiﬁcant difference regarding drainage success,
rate of cholangitis, or survival was seen among Bismuth II, III, and IV
strictures.
Finally, the endoscopist should verbally run through the
procedure and cross-check the necessary accessory devices with
every team member. This simple step alerts and assists the ERCP
team, preventing unnecessary and midprocedural delays.
Cannulation techniques
Conventional approach
Previously published data support a higher success rate and
shorter time in cannulation using a sphincterotome and a guide-
wire when compared with cannulation using a catheter and
contrast injection. Furthermore, cannulation using a guidewire is
less traumatic to the ampulla thanwithout using one. When a tight
tortuous stricture is encountered, using a short (260 cm as opposed
to 450 cm) angled guidewire with a torqueing device facilitates
better navigation through the narrow and tortuous biliary stricture.
Two-wire technique
Not uncommonly, selective bile duct cannulation is difﬁcult due
to the frequent inadvertent cannulation of the pancreatic duct (PD).
In this case, a two-guidewire method could then be attempted. In
this technique, a guidewire is inserted into the PD, and subsequent
sphincterotome-assisted biliary cannulation is attempted using
a second guidewire. The wire in the PD will help prevent repetitive
cannulation of the PD and assist in directing the wire into the bile
duct.6
Precut approach using a needle knife
This can be accomplished by one of the following two techniques
that have similar success and complication rates:
Precut papillotomy: In this method, cutting occurs bymoving the
needle knife from the papillary os toward 11 or 12 o’clock position.
To prevent post-ERCP pancreatitis, it is advisable to place a PD stent
prior to performing precut papillotomy. This also helps orient the
cutting direction toward the bile duct. In skilled hands, the
complication rate of needle-knife sphincterotomywas reported not
to be higher than that of the conventional pull-through sphinc-
terotomy. Cutting should be accurately directed and sufﬁciently
deep so as to allow biliary access, while avoiding any further
unwarranted depth or misdirected cauterization.
Precut ﬁstulotomy: In this method, free-hand cutting occurs
downward from the ampullary infundibulum toward the papilla.
Again, the cutting should be performed deep enough to cut into the
bile duct. Most endoscopists stop cutting prior to reaching
the papillary os to prevent electrocautery-induced tissue edema at
the papilla resulting in post-ERCP pancreatitis.
In a prospective randomized study comparing conventional
over-the-wire technique and precut approach for bile duct cannu-
lation in 291 patients, primary precut approach was found to be as
successful and safe as the conventional approach, with shorter time
spent in achieving cannulation.7
Endoscopic ultrasound-guided ERCP
Endoscopic ultrasound (EUS)-guided biliary drainage has
several variations in technique; however, all methods requirecareful planning and expertise. In the EUS-guided rendezvous
technique, the left hepatic duct or extrahepatic bile duct (preferably
the common bile duct) is punctured with a 19-gauge needle under
EUS guidance, and a guidewire is advanced down to the duodenum
sequentially through the needle, stricture, and the ampulla under
ﬂuoroscopic guidance (Fig. 1). The echoendoscope is then replaced
by a side-viewing scope, and the guidewire is grabbed by a snare.
Once biliary access has been established, conventional ERCP can be
performed. A recent study compared the efﬁcacy of EUS-guided
rendezvous technique and precut papillotomy for biliary access in
difﬁcult cannulation.8 The EUS-guided rendezvous technique had
a signiﬁcantly higher rate of technical success than that of precut
papillotomy [57/58 (98.3%) vs. 130/144 (90.3%); P ¼ 0.03].
Complication rates of the two techniques were similar [precut
group, 6.9% and EUS group, 3.4% (P ¼ 0.27)]. Precut group had one
severe pancreatitis, three moderate pancreatitis, and six cases of
bleeding (ﬁve mild and one moderate). EUS group had two cases of
pericholedochal tracking of contrast with abdominal pain, which
resolved with conservative management within 72 hours. There-
fore, the EUS-guided rendezvous technique appears to offer a high
technical success rate in difﬁcult ERCP cases where conventional
ERCP attempts fail.
Recently, EUS-guided biliary drainage has been described in
several case series. It has applications in caseswhere the rendezvous
procedure may not be possible because of duodenal obstruction or
a difﬁcult hilar stricture. This techniquewas ﬁrst described in 2001.9
Since then, studies have described the use of EUS-guided fully
covered self-expandingmetal stents for patients inwhomERCPwas
unsuccessful due to duodenal stenosis. 10–22 The approach can
be transgastric–transhepatic or transenteric–transcholedochal,
depending on the expertise of the endosonographer and the
requirements of the case. In patients with previously placed biliary
stents, generally a transgastric approach is favored. It involves
puncturing the bile duct, conﬁrming position by injecting a small
amount of contrast and advancing a guidewire in antegrade fashion.
The tract is dilated using a dilator, followed by placement of a metal
stent under ﬂuoroscopic and echoendoscopic guidance. This
approach requires a good echoendoscopic assessment of the
anatomy, especially in the presence of malignancy. In one report of
seven patients, the authors reported failure to perform EUS-guided
biliary drainage in one patient because of unfavorable anatomy.13
The combined placement of a duodenal stent and EUS-guided
biliary drainage in patients with duodenal obstruction and biliary
stricture has also been described in a case series.15
Fig. 2. The patient had duodenal and biliary obstruction due to pancreatic cancer.
Biliary obstruction developed from occlusion of a previously placed metal stent. The
endoscope traversed through the duodenal stent and a plastic biliary stent was placed
within the biliary metal stent.
Fig. 3. In this oblique view, duodenal and biliary metal stents were placed for gastric
outlet obstruction and a biliary stricture.
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biliary drainage in patients with malignant obstructive jaundice.
However, these techniques require an expert endosonographer
and favorable anatomy. When those are not available, a good
alternative with a proven track record is percutaneous trans-
hepatic biliary drainage.
ERCP techniques in malignant gastric outlet obstruction
A duodenal stricture complicates biliary stent placement in 10–
20% of patients with distal biliary obstruction due to pancreatic
cancer. Patients with malignant gastric outlet obstruction can be
palliated by endoscopic placement of a self-expanding metal stent
or by gastrojejunostomy performed either open or laparoscopically.
A vast body of literature has compared the outcome measures of
these two palliative techniques, including procedure-related
morbidity and mortality, time taken by patients in each group to
tolerate oral diet, duration of hospital stay, recurrent symptoms,
need for reinterventions, and cost effectiveness. Three randomized
controlled studies23–25 and many retrospective studies have been
conducted that found similar results.26–35 Results of some of these
studies have also been summarized in systematic reviews and
a meta-analysis.36–38 In general, the endoscopic stent placement is
associated with lower morbidity and mortality, faster tolerance of
oral diet, and shorter hospital stay. However, endoscopic stent
placement is associated with frequent recurrence of symptoms;
thus, reinterventions are often required. No signiﬁcant difference in
30-day mortality was noted in the two groups. Studies comparing
the costs of these two strategies found that endoscopic stent
placement was associated with a lower cost.26,28,29,39 A recent
decision analysis performed also found endoscopic stent placement
to be the dominant and cost-effective strategy compared to the
surgical alternative.40 Based on the ﬁndings of these studies,
endoscopic stent placement is generally considered to be the
preferred procedure to relieve malignant gastric outlet obstruction.
The duodenal stricture might necessitate balloon dilation for
proper duodenoscope positioning and eventual biliary stent
placement. When double stenting (duodenal and biliary) is
considered, biliary stenting can either precede or follow duodenal
stenting (Fig. 2). Stenting of the duodenum immediately after
placement of the biliary stent has the advantage of avoiding
a second procedure for duodenal stenting, but lengthens the initial
endoscopic procedure time. However, this is not always possible
due to the duodenal strictures. Success depends on the location of
the duodenal stricture in relation to the papilla. A study evaluating
the feasibility of double stenting, classiﬁed duodenal strictures into
three types based on the anatomical relation of duodenal stricture
to the papilla41: Type I stenosis (Fig. 3), at the level of the duodenal
bulb or upper duodenal genu (D1), but without involvement of the
papilla; Type II stenosis, affecting the second part of the duodenum
(D2), with involvement of the papilla; and Type III stenosis,
involving the third part of the duodenum (D3), distal to the papilla.
In patients with symptoms due to a signiﬁcant duodenal stricture,
a short duodenal stent can be placed without covering the ampulla,
and, once the stent expands, ERCP can be attempted by passing
a side-viewing scope. Extreme caution should be observed not to
dislodge the duodenal stent during ERCP. When performing
duodenal stenting for Type I or III duodenal stenosis, care should be
taken to avoid covering the papilla. This helps preserve biliary
access for any later intervention, if needed. During a combined
procedure where the duodenal stent is covering the ampullary
region, removal of some of the wires of the duodenal stent’s mesh
with rat-tooth foreign-body forceps may enable bile duct cannu-
lation.42 Selective targeted melting of the mesh wires of the
duodenal stent using argon plasma coagulation is anotheralternative. Recently, duodenal stents with expandable lattices in
the midportion to facilitate identiﬁcation of the ampulla and
insertion of a biliary stent have been described.43 Often identifying
the papilla is challenging in patients with a duodenal stricture in
the second part of the duodenum (Type II stenosis). In such
a patient, biliary cannulation may be easier in the presence of
a previously placed biliary stent compared with a patient who has
a naïve papilla (Fig. 2). Duodenal stents can help open the lumen for
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patients will need EUS guidance or percutaneous assistance in
achieving biliary drainage.
Another technique to consider, that facilitates the passage of the
duodenoscope to the papilla through the duodenal stricture, is
balloon dilation (Fig. 4). In a case series published from Japan, the
authors described two methods to dilate and advance the duode-
noscope to reach the papilla.44 In the ﬁrst method, balloon dilation
(up to a balloon diameter of 20 mm) of the stricture through the
endoscope was initially performed. After the balloon was slightly
deﬂated, the endoscope was simultaneously pushed into the distal
position of the stricture (pushing method). Once the duodenal
stricture was passed, the endoscope was stretched and straightened
to reach thepapilla. If the endoscopecouldnot bepassed through the
duodenal stricture with the pushing method, in the alternative
technique, the balloon was completely deﬂated and then advanced
beyond the stricture into the third portion of the duodenum. The
balloon was then reinﬂated and hooked at the distal position of
the stricture, thereby remaining in the second or third portion of the
duodenum. Finally, the endoscope was straightened, while the
balloon catheter was simultaneously retracted into the working
channel, allowing the endoscope to advance (hooking method). In
most of these cases, after biliary cannulation and drainage,
a duodenal stent was deployed to prevent restenosis of the malig-
nant duodenal stricture. When performed, balloon dilation should
be done gradually considering the severity and length of the stric-
ture. Most importantly, when balloon dilation of the duodenal
stricture is being contemplated, the endoscopist should remember
that perforation and bleeding are signiﬁcant risks, which can result
in a major delay in the treatment of pancreatic cancer.
ERCP in surgically altered anatomy
Patients with a history of surgery for gastrointestinal cancers
may subsequently develop an indication for ERCP. Patients with
gastric, pancreatic, or duodenal cancers who undergo surgery
either for treatment or palliation have surgically altered anatomy.
In such cases, gaining access to the second portion of the
duodenum is a challenge. In a study that used a large dilating
balloon to gain access to the afferent limb in patients with Billroth II
gastrectomy and Roux-en-Y anastomosis,45 the authors described
use of the hooking method to advance the endoscope in the
afferent limb. Other techniques that have been used to accomplish
endoscopic biliary drainage in patients with surgically altered
anatomy include use of double balloon enteroscopy46–48 and
laparoscopy-assisted ERCP.49,50 Again, perforation is a signiﬁcant
risk in advancing the scope through acute turns of the lumen,
created by previous surgery. Thus, extreme caution should beFig. 4. Balloon dilation of stricture at the duodenal bulb (type I stenosis).exercised when performing ERCP in such anatomy, keeping inmind
that there is an alternative, percutaneous approach.ERCP in patients with hematopoietic stem cell transplantation
Performing endoscopic procedures, especially therapeutic
endoscopy, can be challenging in patients who have undergone
hematopoietic stem cell transplantation (HSCT). These patients
frequently face hepatobiliary problems due to either extension of
the underlying disease or unrelated primary biliary problems. Soon
after HSCT, patients develop myelosuppression resulting in
pancytopenia. Pancytopenia creates several challenges for
successful and safe completion of ERCP. Depending on the duration
after HSCT, there is an increased risk of infections due to leuko-
penia. Frequently, patients develop thrombocytopenia increasing
the risk of bleeding during the procedure. Further more, anemia
increases the risk of cardiovascular complications related to anes-
thesia, due to poor reserve. Our group published ERCP experience
in 40 patients who underwent the procedure after HSCT.51 The
median period between HSCT and ERCP was 223 days (range 20–
3805 days). The only procedural complication noted was pancrea-
titis. We emphasized that ERCP should only be performed in
patients who would deﬁnitely beneﬁt from the procedure in this
setting, i.e., patients with imaging evidence of ductal dilation with
abnormal liver enzymes, cholangitis, obstructive jaundice, and/or
common bile duct stones. Another study reported the outcomes of
ERCP in 16 patients who had undergone HSCT.52 The indication in
the majority of the patients was ascending cholangitis or obstruc-
tive jaundice. There was only one complication of minor bleeding
related to sphincterotomy. In this study, the average platelet count
in the patients undergoing sphincterotomy was 151  103 /mm3
(range 27–403  103 /mm3). Regrettably, the number of patients in
the study was inadequate to draw any conclusion regarding the
minimum number of platelets required for safe sphincterotomy.Cholangiopancreatoscopy
Cholangiopancreatoscopy (CPS) is a useful armamentarium in
establishing diagnoses and providing treatments in biliary and
pancreatic disorders. However, in order to be successful in CPS, one
has to understand the mechanics of the instruments, procedure
techniques, and, most of all, appropriate clinical applications.
One of the clinical applications of CPS is electrohydraulic litho-
tripsy for a large stone imbedded in the biliary tree. CPS is not
necessary for ordinary biliary stone removal or visualizing a tumor
with an established diagnosis. Stones located in the distal body or
the tail of the PD are difﬁcult to manage evenwith pancreatoscopy,
especially if the duct is narrow in the head and neck of the
pancreas. Hence, indications for CPS include unknown strictures in
the bile duct or PD, large stones that are not retrievable by a basket
or a balloon, and intraductal papillary mucinous neoplasm (to
identify intraoperatively the extent of pancreatic ductal involve-
ment). When performing CPS, sphincterotomy is necessary and the
duct caliber has to be larger than the scope diameter. Gentle water
irrigation is intermittently needed to optimize visualization. In
performing pancreatoscopy, it is difﬁcult to advance the scope
through the genu, especially in a tortuous PD, and the scope should
be advanced over the guidewire to minimize pancreatic ductal
injury.53 An ultraslim upper endoscope can be used for visual
examination and therapeutic interventions of the bile ducts;
however, this requires careful maneuvering of the scope over
a guidewire placed in a branch of the intrahepatic duct, keeping in
mind that excessive water irrigation without proper concurrent
draining or excessive use of air can result in complications.
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ERCP complications include pancreatitis, bleeding, infection,
bowel perforation, and others with the most common being
pancreatitis. Pancreatitis ranges from mild to severe cases and can
even result in fatal outcomes. In a large retrospective study of
11,497 ERCP procedures over 12 years, a total of 462 complications
(4.0%) were reported, with 42 being severe (0.36%) and seven fatal
(0.06%).54 Pancreatitis was most common (2.6%). Overall compli-
cations were more likely among individuals with suspected
sphincter of Oddi dysfunction (OR ¼ 1.91) and following a biliary
sphincterotomy (OR ¼ 1.32). Patients with prior pancreatitis
(OR ¼ 0.78) or who received a temporary pancreatic stent
(OR ¼ 0.69) had fewer complications. Biliary sphincterotomy was
associated with bleeding (OR ¼ 4.71). Severe or fatal complications
were associated with poor health status, obesity, known or sus-
pected bile duct stones, pancreatic manometry, and complex
procedure. Therefore, if a patient has predictors of severe or fatal
ERCP complications, perhaps preventative measures should be
considered, such as observation in the hospital and/or pancreatic
ductal stent placement when appropriate.
In summary, ERCPs frequently pose unique and unforeseeable
challenges. Subtle changes and adjustments in techniques are often
needed for successful cannulation. By far, the most important
characteristics that an endoscopist should have, for safe and
effective outcomes, are patience and perseverance. An endoscopy
team composed of well-trained staff with experience is invaluable.
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